Decision letter: Organelle proteomic profiling reveals lysosomal heterogeneity in association with longevity
Year: 2023
Type: peer-review
Abstract: Full text Figures and data Peer review Side by side Abstract Editor's evaluation Introduction Results Discussion Materials and methods Data availability References Article and author information Metrics Abstract Lysosomes are active sites to integrate cellular metabolism and signal transduction. A collection of proteins associated with the lysosome mediate these metabolic and signaling functions. Both lysosomal metabolism and lysosomal signaling have been linked to longevity regulation; however, how lysosomes adjust their protein composition to accommodate this regulation remains unclear. Using deep proteomic profiling, we systemically profiled lysosome-associated proteins linked with four different longevity mechanisms. We discovered the lysosomal recruitment of AMP-activated protein kinase and nucleoporin proteins and their requirements for longevity in response to increased lysosomal lipolysis. Through comparative proteomic analyses of lysosomes from different tissues and labeled with different markers, we further elucidated lysosomal heterogeneity across tissues as well as the increased enrichment of the Ragulator complex on Cystinosin-positive lysosomes. Together, this work uncovers lysosomal proteome heterogeneity across multiple scales and provides resources for understanding the contribution of lysosomal protein dynamics to signal transduction, organelle crosstalk, and organism longevity. Editor's evaluation The authors present a powerful tool to unbiasedly identify lysosome-associated proteins in C. elegans, and they provide a compelling, in-depth assessment of how this method can be used to understand longevity pathways and identify novel proteins. Understanding lysosomal differences in specific tissues or in response to different longevity conditions are exciting as it provides new insight into how organelles could control specific homeostasis responses. This valuable tool and proteomics datasets also represent a great resource for the C. elegans community and should pry open new studies on the regulation and role of the lysosome at the organismal level. https://doi.org/10.7554/eLife.85214.sa0 Decision letter Reviews on Sciety eLife's review process Introduction Lysosomes are membrane-bound organelles specialized to constitute an acidic environment in the cytosol. Lysosomes carry many proteins that are essential for maintaining lysosomal activities and mediating lysosomal regulatory effects. Inside the lysosomal lumen, a series of acidic hydrolases, including lipases, proteases, glucosidases, acid phosphatases, nuclease, and sulfatases, are responsible for the degradation and recycling of extra- and intracellular materials delivered through endocytic, phagocytotic, and autophagic processes (Appelqvist et al., 2013; Ballabio and Bonifacino, 2020; Lawrence and Zoncu, 2019). Additionally, on the lysosomal membrane, a group of integral transmembrane proteins play crucial roles in the maintenance of luminal acidic pH and ion homeostasis, the control of lysosomal membrane potential and export of metabolic products, as well as the regulation of organelle interaction and signal transduction (Ballabio and Bonifacino, 2020; Lawrence and Zoncu, 2019). For example, the lysosomal vacuolar-type H+-ATPase (v-ATPase) on the membrane is the primary driver for the active accumulation of protons in the lysosomal lumen, which also requires a neutralizing ion movement mediated by ion channels and transporters (Graves et al., 2008; Nicoli et al., 2019). In addition, v-ATPase coordinates with lysosomal amino acid transporter SLC38A9 and lysosomal cholesterol exporter NPC1 in regulating the activation of mechanistic/mammalian target of rapamycin complex I (mTORC1) by amino acid and lipid cues (Castellano et al., 2017; Wang et al., 2015). The recruitment of mTORC1 to the lysosome is mediated by RagA/B and RagC/D GTPase heterodimers that are associated with the scaffold protein complex Ragulator tethered on the lysosomal membrane (de Araujo et al., 2017). Through interacting with Axin, Ragulator also mediates the activation of AMP-activated protein kinase (AMPK) on the lysosomal surface (Zhang et al., 2014). Furthermore, lysosomes are not static, isolated organelles, instead they are highly mobile vesicles that undergo frequent movements in both anterograde (nucleus-to-periphery) and retrograde (periphery-to-nucleus) directions and form dynamic interactions with other organelles including endosomes, autophagosomes, endoplasmic reticulum (ER), and mitochondria (Ballabio and Bonifacino, 2020; Pu et al., 2016). These trafficking and interaction processes are mediated by lysosomal integral transmembrane proteins as well as diverse proteins that are recruited to lysosomes in response to different extra- and intracellular inputs (Ballabio and Bonifacino, 2020; Pu et al., 2016). Lysosomes control numerous cellular processes, and dysfunction of lysosomes has been linked with various diseases, such as lysosomal storage disorders (Ballabio and Gieselmann, 2009; Platt et al., 2012), Alzheimer's disease (Nixon and Cataldo, 2006), Parkinson disease (Navarro-Romero et al., 2020), and some types of cancer (Davidson and Vander Heiden, 2017; Fehrenbacher and Jäättelä, 2005). Emerging evidence also suggests that lysosome functions as a central regulator of organism longevity, through its involvement in autophagy and its modulation of metabolic signaling pathways. The induction of autophagic flux has been observed in multiple pro-longevity states, and is required for the pro-longevity effects caused by those genetic, dietary, and pharmacological interventions, such as reduced insulin/IGF-1 signaling, caloric restriction, and spermidine treatment (Hansen et al., 2018; O'Rourke et al., 2013; Lapierre et al., 2011). On the other hand, lysosomes are now recognized as the key platform to modulate the activities of mTORC1 and AMPK signaling, two well-characterized longevity regulating pathways (Savini et al., 2019). In addition, our studies have discovered lysosomal lipid messenger pathways that are induced by a lysosomal acid lipase LIPL-4 and promote longevity via both cell-autonomous and cell-nonautonomous signaling mechanisms (Folick et al., 2015; Ramachandran et al., 2019; Savini et al., 2022; Wang et al., 2008). Given the importance of lysosomes in regulating longevity, it will be crucial to understand how changes in the lysosomal protein composition are associated with longevity regulation. To systemically profile the protein composition of lysosomes, methods have been developed to purify lysosomes using gradient centrifugation (Gao et al., 2017; Lübke et al., 2009; Markmann et al., 2017; Schröder et al., 2010). More recently, a lysosome immunoprecipitation method, which uses anti-HA (human influenza virus hemagglutinin) antibody-conjugated magnetic beads to immuno-purify lysosomes from mammalian cells expressing transmembrane protein 192 (TMEM192) fused with three tandem HA (3×HA) epitopes, has further improved the specificity and speed of lysosomal isolation (Abu-Remaileh et al., 2017). This rapid isolation method has facilitated follow-up mass spectrometry (MS)-based proteomics as well as metabolomics analyses (Abu-Remaileh et al., 2017; Eapen et al., 2021; Laqtom et al., 2022). In the present study, we have applied an immunoprecipitation-based method for rapid isolation of lysosomes from live adult Caenorhabditis elegans using transgenic strains expressing lysosomal membrane proteins tagged with 3×HA (Lyso-Tag). We then conducted large-scale proteomic profiling using isolated lysosomes and remaining non-lysosomal fractions, to determine the enrichment of each identified protein on the lysosome. Based on these analyses, we have defined a lysosome-enriched proteome and compared it between wild-type (WT) and long-lived worms, revealing lysosomal protein composition changes associated with longevity. We have also generated transgenic strains expressing Lyso-Tag specifically in four major somatic tissues, the hypodermis (epidermis), muscle, intestine (digestive tract/fat tissue/liver), and neurons, leading to the discovery of lysosomal proteome heterogeneity in different tissues. Furthermore, by comparing the lysosome-enriched proteome with LAMP1/LMP-1 Lyso-Tag and the one with Cystinosin/CTNS-1 Lyso-Tag, we discovered that the Ragulator complex and other mTORC1 regulators exhibit increased enrichments on lysosomes containing the cysteine transporter Cystinosin. Results Map lysosome-enriched proteome systemically in C. elegans To comprehensively reveal proteins that are enriched at the lysosome, we have applied rapid lysosome immunoprecipitation followed by MS-based proteomic profiling (Lyso-IP) (Figure 1A). We first generated a transgenic strain overexpressing the lysosome-associated membrane protein, LMP-1 (Eskelinen, 2006) fused to both 3×HA and RFP (LMP-1 LysoTg) under the whole-body sur-5 promoter. Fluorescence imaging of RFP confirmed the lysosomal localization of the LMP-1 fusion protein in live organisms and made it possible to follow purified lysosomes in vitro (Figure 1B). The presence of transgenes does not affect worms' developmental timing and lifespan (Figure 1—figure supplement 1A, B). The 3×HA epitope tag is used to purify lysosomes from homogenized worm lysate via immunoprecipitation using anti-HA antibody-conjugated magnetic beads (Figure 1A). In general, about 160,000 worms at day-1 adulthood were harvested and homogenized. Upon centrifugation to remove debris and nuclei, 3×HA-tagged lysosomes were immunoprecipitated and separated from other cellular content (flow-through controls, Figure 1A). The whole process from harvesting worms to purified lysosomes takes around 25 min. Many purified lysosomes were able to take up LysoTracker probes and exhibit positive fluorescence signals, indicating that they remain intact with an acidic pH, while there are also some broken lysosomes losing LysoTracker staining (Figure 1C). When blotting with antibodies against different organelle markers, we found that the purified lysosomes show no or nearly no protein markers of other organelles, including HSP-60 (mitochondria heat shock protein) (Hartl et al., 1992; Mayer, 2010), CYP-33E1 (ER cytochrome P450) (Brown and Black, 1989), SQV-8 (Golgi glucuronosyltransferase) (Hadwiger et al., 2010), and β-actin (cytoskeleton) (Figure 1D), while the flow-through controls show these protein markers but nearly no lysosomal protein marker LMP-1 (Figure 1D). Together, these results demonstrate the efficacy of the Lyso-IP approach to enrich lysosomal proteins. Figure 1 with 1 supplement see all Download asset Open asset Rapid lysosome isolation coupled with proteomic profiling. (A) Schematic of the workflow for immunoprecipitation-based lysosome purification (Lyso-IP) and mass spectrometry-based proteomic profiling to identify lysosome-enriched proteomes in C. elegans.(B) Example images of transgenic strains carrying LMP-1 Lyso-Tag (LMP-1::RFP-3×HA) with LysoTracker staining to mark lysosomes in vivo. Scale bar = 5 µm. (C) Example images of beads carrying purified lysosomes from Lyso-IP with LysoTracker staining to mark intact lysosomes in vitro. Scale bar = 5 µm.(D) Western blot for protein markers of different subcellular compartments using purified lysosomes (Lyso-IP), paired non-lysosomal fractions (Flow-through) or Pellet. (E) Principal components analysis (PCA) of four independent biological replicates of Lyso-IP and Flow-through samples. Figure 1—source data 1 Western blots shown in Figure 1. https://cdn.elifesciences.org/articles/85214/elife-85214-fig1-data1-v2.zip Download elife-85214-fig1-data1-v2.zip Next, we conducted proteomic profiling of purified lysosomes with their paired flow-through controls (Figure 1A). The correlation analysis shows good reproducibility among four independent biological replicates (Figure 1—figure supplement 1C), and the principal components analysis (PCA) shows a clear separation between Lyso-IP replicates and flow-through controls (Figure 1E). In parallel, we also conducted immunoprecipitation using homogenized lysate from WT worms that do not carry a Lyso-Tag and then analyzed proteomic profiles of three independent samples as non-tag controls (Figure 1A). Based on these proteomic data, we used three criteria to define lysosome-enriched proteins: first, their levels in the purified lysosomes are 10-fold or higher than those in the flow-through controls (Figure 2A); second, their enrichments can be repeated in all biological replicates (Figure 2A); and lastly, their enrichments over non-tag controls are more than 2-fold (Figure 2B). Together, 216 lysosome-enriched candidates were identified from more than 6000 detected proteins, and 178 candidates have mammalian homologs (Figure 2—figure supplement 1, Supplementary file 1). This lysosome-enriched proteome consists of 83 membrane transporters and channels, 47 enzymes, 26 signaling factors, 12 structural components, and 6 involved in vesicle trafficking (Figure 2C). These include known lysosomal proteins, such as various lysosomal Cathepsins that catalyze protein degradation (Turk et al., 2012), lysosomal specific ARL8 GTPase that mediates lysosome trafficking (Nakae et al., 2010), and subunits of lysosomal v-ATPase that pumps protons into the lysosomal lumen to maintain an acidic pH (Forgac, 2007; Supplementary file 1). Figure 2 with 1 supplement see all Download asset Open asset Systematic view of lysosome-enriched proteome. (A) Scatter plots showing candidate selection from four independent biological replicates in proteomics analyses. Proteins with at least 10-fold higher levels in Lyso-IP samples than in flow-through (FT) controls are highlighted with different colors based on repeated times in four replicates. (B) Scatter plot showing candidate selection with normalization to non-tagged controls using wild-type worms. 216 proteins with over twofold higher levels in Lyso-IP samples than in non-tagged controls are highlighted in red. (C) Pie chart showing molecular function categories of lysosome-enriched proteins. (D) The lysosomal enrichment ratio (Lyso-IP vs. FT) for each subunit of lysosomal vacuolar ATPase (v-ATPase) in four independent replicates is shown. Inserted scheme showing lysosomal V-ATPase assembly. (E) Pie chart showing subcellular location categories of lysosome-enriched proteins. Lysosomal v-ATPase consists of both V0 and V1 domains that are associated with the lysosomal membrane and face the cytosol, respectively (Figure 2D). Reversible dissociation of the V1 and V0 domains responds to nutritional signals and plays a crucial role in the regulation of the lysosomal v-ATPase activity (Kane, 1995; McGuire and Forgac, 2018; Ratto et al., 2022; Stransky and Forgac, 2015). Except for VHA-18 (V1 H subunit), we were able to detect all other subunits of lysosomal v-ATPase, including VHA-5, 6, 7 and UNC-32 (V0 a subunits), VHA-1, 2, 3 and 4 (V0 c subunits), VHA-16 (V0 d subunit), VHA-17 (V0 e subunit), VHA-13 (V1 A subunit), VHA-12 (V1 B subunit), VHA-11 (V1 C subunit), VHA-14 (V1 D subunit), VHA-8 (V1 E subunit), VHA-9 (V1 F subunit), VHA-10 (V1 G subunit), and VHA-15 (V1 H subunit), and also two v-ATPase transporting accessory proteins, VHA-19 and VHA-20 (Figure 2D, Supplementary file 1). Among the V0 domain subunits, VHA-4, 5, 6, 7, and 16 and UNC-32 are enriched over 10-fold in all four replicates, VHA-1, 2, and 3 are enriched over 10-fold in three replicates and over 5-fold in one replicate, and the low abundant VHA-17 was only detected in two replicates, with more than 10-fold enrichments in both (Figure 2D). The VHA-19 transporting accessory protein is enriched over 10-fold in two replicates and less than 5-fold in two replicates (Figure 2D). In contrast, for the subunits of the V1 domain and the VHA-20 transporting accessory protein, they show no enrichment in the purified lysosomes compared to the flow-through controls (Figure 2D). These results suggest that the free form of the V1 domain and the associated form bound with the V0 domain at lysosomes both exist under well-fed condition in WT worms. In addition to 30.7% of proteins with known lysosome/endosome localization, the lysosome-enriched proteome includes a small portion of proteins localized to other cellular organelles, ER/Golgi (6.0%), mitochondria (1.4%), peroxisome (0.4%), lipid droplet (0.9%), and synaptic vesicle (1.8%) (Figure 2E). On the other hand, there is a large portion of proteins with annotated plasma membrane localization (24.8%) (Figure 2E). Many of these plasma membrane proteins are receptors that are known to be subject to endocytosis and subsequent recycling lysosomal degradation, such as INA-1/integrin alpha-6 (De Franceschi et al., 2015), VER-3/vascular endothelial growth factor receptor (Ewan et al., 2006), PTC-1/protein patched receptor (Gallet and Therond, 2005), and IGLR-2/leucine-rich repeat-containing G-protein-coupled receptor (Snyder et al., 2013; Supplementary file 1; Braulke and Bonifacino, 2009). We also identified proteins involved in the endocytosis process, including low-density lipoprotein receptor-related proteins, LRP-1 (Grant and Hirsh, 1999) and arrestin domain-containing proteins, ARRD-13 and ARRD-18 (Kang et al., 2014; Supplementary file 1) that mediate the internalization of plasma membrane receptors (Ma et al., 2002). Thus, the lysosome-enriched proteome also reveals membrane receptor proteins that undergo recycling through the endo-lysosomal system. Profile lysosome-enriched proteome heterogeneity among different tissues Lysosomes are known as a heterogeneous population of vesicles, differing in their size, shape, pH, and cellular distribution. They broadly exist in all tissues of an organism and play diverse roles in a tissue-specific manner. To examine how lysosome-enriched proteomes exhibit heterogeneity among different tissues, we have generated four transgenic strains that overexpress LMP-1 Lyso-Tag specifically in neurons, muscle, intestine, and hypodermis using tissue-specific promoters, unc-119, myo-3, ges-1, and col-12, respectively (Figure 3A). Using these transgenic strains, we purified lysosomes in a tissue-specific manner and conducted proteomic profiling. The correlation analysis shows good reproducibility among three independent biological replicates (Figure 3—figure supplement 1A-D). Figure 3 with 1 supplement see all Download asset Open asset Lysosomal proteome heterogeneity across tissues. (A) Example images of transgenic strains carrying Lyso-Tag (LMP-1::RFP-3×HA) driven by four different tissue-specific promoters. Scale bar = 20 μm. Scatter plot showing the relative enrichment ratio for each of 216 lysosome-enriched proteins identified from whole-body LMP-1 Lyso-IP in comparison with tissue-specific LMP-1 Lyso-IPs, hypodermis (B), muscle (C), intestine (D), and neuron (E). X-axis, enrichment ratio tissue-specific vs. whole-body; Y-axis, normalized protein abundance over LMP-1; each dot represents the average of three replicates. (F) Heatmap showing the relative enrichment of 216 lysosome-enriched proteins identified from whole-body LMP-1 Lyso-IP in comparison with tissue-specific LMP-1 Lyso-IPs. Group I, comparable ratios between whole-body and tissue-specific Lyso-IPs; Group II, increase in tissue-specific Lyso-IPs (p < 0.05 by Student's t-test); Group III, decrease in tissue-specific Lyso-IPs (p < 0.05 by Student's t-test); Group IV, absent in tissue-specific IPs. Unlike the whole-body Lyso-IP, the flow-through samples from tissue-specific Lyso-IP contain not only non-lysosomal fractions from the targeted tissue but also lysosomes from non-targeted tissues. Thus, these flow-through samples cannot be simply used as controls to determine the enrichment of proteins at the lysosome in the targeted tissue. To assess tissue-specific changes, we have normalized the level of each identified protein to the level of LMP-1 in the same replicate, and then compared the normalized ratio between the whole-body Lyso-IP and the tissue-specific Lyso-IP (Figure 3B–E, Supplementary file 2). We found that among the 216 proteins identified from the whole-body Lyso-IP, 85 of them show comparable ratios between the whole-body Lyso-IP and the four tissue-specific Lyso-IPs (Figure 3F, Group I), suggesting relative homogenous lysosomal enrichments of these proteins among different tissues. Nine of them were completely absent in the tissue-specific Lyso-IP, which may be related to their low abundance (Figure 3F, Group IV). Furthermore, there are 122 proteins that exhibited significant differences in their enrichments between the whole-body Lyso-IP and the tissue-specific Lyso-IPs (p < 0.05), 56 of them (Group II) showing an increase in the tissue-specific Lyso-IPs while the other 66 (Group III) showing a decrease (Figure 3F). One of the candidates in Group II is Y58A7A.1, a copper uptake transporter, that shows a higher ratio in the hypodermis (Figure 3F). Copper transporters are crucial players in various biological processes and copper dysfunction contributes to oxidative stress, impaired respiration and enzymic activities, and disease progression. To validate whether Y58A7A.1 is a copper transporter specifically localized at the lysosome in the hypodermis, we generated a CRISPR knock-in line where the endogenous Y58A7A.1 is tagged with mNeonGreen. Using this line, we confirmed the hypodermis-specific lysosomal localization of Y58A7A.1 (Figure 3—figure supplement 1E). These results show that the lysosomal proteome exhibits heterogeneity among different tissues within the organism, which may be related to the metabolic status in each tissue and, consequently, contribute to the specific activities and signaling effects of the tissue. Our studies provide a list of candidates for further investigation into the tissue-specific regulation of lysosomal metabolism and signaling. Lysosome-enriched proteome alterations associate with different pro-longevity mechanisms Considering the emerging role of lysosomes as a cellular hub to integrate protein signals and longevity, we whether the protein composition of lysosomes exhibits heterogeneity in with different longevity mechanisms. To this we LMP-1 with four different long-lived the transgenic strain that a lysosomal acid lipase (Folick et al., 2015), the of that the insulin/IGF-1 receptor et al., et al., the of that complex activity et al., and the that has a at and Figure We then conducted Lyso-IP proteomic analyses and compared lysosome-enriched proteomes between WT and long-lived The correlation analysis shows good reproducibility among three independent biological replicates (Figure supplement and the analysis shows a clear separation between Lyso-IP replicates and flow-through controls (Figure supplement Figure 4 with 1 supplement see all Download asset Open asset Lysosomal proteome in different pro-longevity (A) showing four different longevity regulatory mechanisms used in this of and complex III, insulin/IGF-1 signaling, and leading to lifespan while lysosomal by transgenic longevity. (B) showing the between the lysosome-enriched proteomes from wild-type (WT) and worms. (C) showing the and of lysosome-enriched proteins across the four pro-longevity Inserted showing the between the lysosome-enriched proteomes of WT worms and the long-lived and In the worms, we have identified lysosome-enriched proteins file and of them with the candidates from WT worms (Figure Thus, of proteins enriched on WT lysosomes are also enriched on however, of proteins enriched on lysosomes are absent in WT lysosomes (Figure In parallel, lysosome-enriched proteins were identified in the using LMP-1 Lyso-IP file of them with the LMP-1 Lyso-IP candidates from WT worms, of them with the LMP-1 Lyso-IP candidates from the worms, and to the (Figure In the we identified lysosome-enriched proteins file Among 26 candidates are to the while and candidates with those in the and worms, respectively (Figure lysosome-enriched proteins were identified in the file When compared to the control worms at the same file were to the while with WT candidates (Figure supplement there is only one lysosome-enriched candidate among all four long-lived strains but absent from the WT lysosome-enriched proteome (Figure supplement suggesting that pro-longevity mechanisms the protein composition of the lysosome in their specific Furthermore, for the long-lived and worms, the of their lysosome-enriched proteome with the WT are and (Figure Figure supplement These are higher than the observed between the long-lived worms and the WT (Figure These results that increased lysosomal to changes on lysosomal protein composition than other pro-longevity mechanisms. In the and the lysosome-enriched we found the enrichment of proteins and proteins that mediate the fusion between and lysosomes, including and and and (Figure which is with the induction of autophagy in these long-lived conditions et al., and 2018; O'Rourke et al., Figure 5 Download asset Open asset enrichment of lysosomal proteins lysosomal lipolysis. (A) protein levels across of components, mTORC1 signaling factors, lysosomal v-ATPase and transporting accessory subunits, lysosomal and transporter proteins from LMP-1 Lyso-IP proteomic analyses of wild-type and worms at and WT and worms at (B) The lysosomal enrichment ratio (Lyso-IP vs. FT) for two homologs of AMP-activated protein kinase (AMPK) subunits, and in and worms. (C) of AMPK using the of with lifespan by and in the WT and a the lifespan caused by is reduced from to < by The lifespan data are also in Supplementary file In addition, we found that the Ragulator and that as a scaffold for the activation of mTORC1 and AMPK (Zhang et al., shows a higher enrichment at the lysosome from the worms than WT (Figure such increased enrichments were not detected in the lysosome from the or (Figure is known that the Ragulator complex mediates the lysosomal activation of AMPK (Zhang et al., 2014). are two homologs of AMPK and in C. We found that is enriched more than 10-fold in the Lyso-IP samples compared to the flow-through controls from the worms, but it is only detected in the flow-through controls from WT worms (Figure to its low was detected in the Lyso-IP samples from the worms but only in the flow-through from WT worms (Figure On the other hand, and were not present in the lysosome-enriched proteome from the or (Figure These results suggest that AMPK is specifically recruited to the lysosomal surface in the worms, which may contribute to the pro-longevity To this we AMPK using the with the We found that the AMPK the of the and WT worms by and and the lifespan caused by from to (Figure Supplementary file Thus, and are responsible for the lifespan caused by For the AMPK subunits, is known that the activation of AMPK
Source: eLife
Language: English
Subfield: Aging
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,500
OpenAlex ID: W4391948266
